Reimagine Care Investors


Devin Carty

CEO of Martin Ventures

Devin is the CEO of Martin Ventures, a healthcare-focused venture capital firm, where he leads the investment committee, builds and scales de novo companies, and provides oversight for 20+ portfolio companies. Devin has also cofounded several companies, including Reimagine Care, Wellvana Health, Trilliant Health, and Clariture Health. Prior to Martin Ventures, Devin served as EVP, chief talent officer, and chief strategy officer for Cancer Treatment Centers of America, chief experience officer and chief marketing officer for Vanguard Health Systems, a partner on the healthcare team for Gallup Consulting, a scientist with NASA and a medical missionary in the Congo Africa. 


Doug French

Co-Founder and Managing Director of Sante Ventures 

Doug is Co-Founder and Managing Director of Santé Ventures and commands more than 30 years experience as a distinguished healthcare executive. As a Fellow at the American College of Healthcare Executives, he has spoken extensively on leadership development, healthcare ventures, collaboration and reform. Prior to founding Santé Ventures, Doug was President and CEO of Ascension Health, the largest nonprofit system in the United States, as well as Founder of Ascension Ventures. Doug serves on the Board of Directors for several companies, including Herman Miller, Inc.


Keith Figlioli

Partner, LRVHealth

Keith is a healthcare technology and services executive with deep experience in both public and private high-growth companies. He joined LRVHealth in 2016 to leverage a track record of creating, building and investing in transformative healthcare companies, and has led the firm’s investments in IntelyCare, Genome Medical, Upfront Healthcare and Reimagine Care. Keith was previously a senior executive at Premier, Inc. where he oversaw the company’s enterprise healthcare and technology business unit and supported the company and its network through an $820M IPO. Prior to Premier, he held multiple executive roles at Eclipsys (now NASDAQ: MDRX). Keith is also a former member of the ONC HIT Standards Committee.